Products Liability
Dupixent (Dupilumab) Products Liability Litigation
Pending actions
28
Historical total
29
Resolved / remanded
1
Newly Centralized. Consolidated within the last 18 months. Of 29 lawsuits ever part of this litigation, 28 remain active.
About this litigation
Dupixent (Dupilumab) Products Liability Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Products Liability docket. It was centralized on June 4, 2026 before Zahid N. Quraishi, U.S. District Judge, in the D. New Jersey.
As of the August 3, 2026 JPML report, 28 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Products Liability MDLs
View categoryJohnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
68,914
pending actions
MDL 2738
D. New Jersey
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
23,321
pending actions
MDL 2846
S.D. Ohio
Aqueous Film-Forming Foams Products Liability Litigation
15,246
pending actions
MDL 2873
D. South Carolina
Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation
11,779
pending actions
MDL 3060
N.D. Illinois